CD40L is critical for protection from demyelinating disease and development of spontaneous remyelination in a mouse model of multiple sclerosis

Brain Pathology

Volumn 10, Issue 1, 2000, Pages 1-15

  Drescher, Kristen M ^a   Zoecklein, Laurie J ^a   Pavelko, Kevin D ^a   Rivera Quinones, Cynthia ^a   Hollenbaugh, Diane ^b   Rodriguez, Moses ^a,c  

^a MAYO GRADUATE SCHOOL   (United States)

^b BRISTOL MYERS SQUIBB   (United States)

^c MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLYCOPROTEIN GP 39;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CEREBELLUM DISEASE; CONTROLLED STUDY; CORPUS STRIATUM; CYTOTOXIC T LYMPHOCYTE; DEMYELINATING DISEASE; FEMALE; IMMUNE RESPONSE; MOUSE; MULTIPLE SCLEROSIS; MURINE ENCEPHALOMYELITIS VIRUS; NONHUMAN; REMYELINIZATION; SPINAL CORD DISEASE; WHITE MATTER;

EID: 0033958621     PISSN: 10156305     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1750-3639.2000.tb00238.x     Document Type: Article

References (61)

1. Asakura K, Miller DJ, Pease LR, Rodriguez M (1998) Targeting of IgMk antibodies to oligodendrocytes promotes central nervous system remyelination. J Neurosci 18: 7700-7708
2. Aubert C, Chamorro M, Brahic M (1987) Identification of Theiler's virus infected cells in the central nervous system of the mouse during demyelinating disease. Microb Pathog 3: 319-326
3. b gene become resistant to persistent infection by Theiler's virus. J Virol 68: 4049-4052
4. Campbell KA, Ovendale PJ, Kennedy MK, Fanslow WC, Reed SG, Maliszewski CR (1996) CD40 ligand is required for protective cell-mediated immunity to Leishmania major. Immunity 4: 283-289
5. Cash E, Bandeira A, Chirinian S, Brahic M (1989) Characterization of B lymphocytes present in the demyelinating lesionS induced by Theiler's virus. J Immunol 1989, 143: 984-988
6. Cash E, Bandeira A (1991) Effector T lymphocytes present in demyelinating lesions induced by Theiler's virus. Viral Immunol 4: 53-57
7. Clatch RJ, Melvold RW, Miller SD, Lipton HL (1985) Theiler's murine encephalomyelitis virus (TMEV)-induced demyelinating disease in mice is influenced by the H-2D region: correlation with TMEV-specific delayed-type hypersensitivity. J Immunol 135: 1408-141
8. Clatch RJ, Miller SD, Metzner R, Dal Canto MC, Lipton HL (1990) Monocytes/macrophages isolated from the mouse central nervous system contain infectious Theiler's murine encephalomyelitis virus (TMEV). Virology 176: 244-254
9. Dal Canto MC, Lipton HL (1975) Primary demyelination in Theiler's virus infection. An ultrastructural study. Lab Invest 33: 626-637
10. Dal Canto MC, Lipton HL (1982) Ultrastructural immunohistochemical localization of virus in acute and chronic demyelinating Theiler's virus infection. Am J Pathol 106: 20-29
11. Drescher KM, Murray PD, David CS, Pease LR, Rodriguez M (1999) CNS cell populations are protected from virus-induced pathology by distinct arms of the immune system. Brain Pathol 9: 21-31
12. Drescher KM, Rivera-Quinones C, Lucchinetti CF, Rodriguez M (1998) Failure of linomide or oral myelin tolerization to ameliorate demyelination in a viral model of multiple sclerosis. J Neuroimmunol 88: 111-119
13. Durie FH, Fava RA, Foy FM, Arruffo A, Ledbetter JA, Noelle RJ (1993) Prevention of collagen-induced arthritis with an antibody to gp39, the ligand for CD40. Science 261: 1328-1330
14. Fiette L, Aubert C, Brahic M, Rossi CP (1993) Theiler's virus infection of beta 2-microglobulin-deficient mice. J Virol 67: 589-592
15. Fiette L, Aubert C, Muller U, Huang S, Auget M, Brahic M, Bureau JF (1995) Theiler's virus infection of 129 Sv mice that lack the interferon α/β or interferon γ receptors. J Exp Med 181: 2069-2076
16. Fiette L, Brahic M, Pena-Rossi C (1996) Infection of class-II deficient mice by the DA strain of Theiler's virus. J Virol 70: 4811-4815
17. Foy TM, Laman JD, Ledbetter JA, Aruffo A, Claassen E, Noelle RJ (1994) gp39-CD40 interactions are essential for germinal center formation and the development of B cell memory. J Exp Med 180: 157-163
18. Foy TM, Shepherd DM, Durie FH, Aruffo A, Ledbetter JA, Noelle RJ (1993) In vivo CD40-gp39 interactions are essential for thymus-dependent humoral immunity. II. Prolonged suppression of the humoral immune response by an antibody to the ligand for CD40, gp39. J Exp Med 178: 1567-1575
19. Gerritse K, Laman JD, Noelle RJ, Arruffo A, Ledbetter JA, Boersma WJA, Claassen E (1996) CD40-CD40 ligand interactions in experimental allergic encephalomyelitis and multiple sclerosis. Proc Nat Acad Sci USA 93: 2499-2504
20. Grewal IS, Flavell RA (1998) CD40 and CD154 in cell-mediated immunity. Ann Rev Immunol 16: 111-135
21. Howard LM, Miga AJ, Vanderlust CL, Dal Canto MC, Laman JD, Noelle RJ, Miller SD (1999) Mechanisms of immunotherapeutic intervention by anti-CD40L (CD154) antibody in an animal model of multiple sclerosis. J Clin Invest 103: 281-290
22. Johnson AJ, Njenga MK, Hansen MJ, Kuhns ST, Chen LP, Rodriguez M, Pease LR (1999) Prevalent class I-restricted T-cell response to the Theiler's virus epitope D-b: VP2(121-130) in the absence of endogenous CD4 help, tumor necrosis factor alpha, gamma interferon, perforin, or costimulation through CD28. J Virol 73: 3702-3708
23. Lang W, Rodriguez M, Lennon VA, Lampert, PW (1984) Demyelination and remyelination in murine viral encephalomyelitis. Ann NY Acad Sci 436: 98-102
24. Lin X, Pease LR, Rodriguez M (1997) Differential generation of Class I H-2D-versus H-2K-restricted cytotoxicity against a demyelinating virus following central nervous system infection. Eur J Immunol 27: 963-970
25. Lin X, Thiemann R, Pease LR, Rodriguez M (1995) VP1 and VP2 capsid proteins of Theiler's virus are targets of H-2D-restricted cytotoxic lymphocytes in the central nervous system of B10 mice. Virology 214: 91-99
26. Lindsley MD, Patick AK, Prayoonwiwat N, Rodriguez M (1992) Coexpression of class I major histocompatibility antigen and viral RNA in central nervous system of mice infected with Theiler's virus: a model for multiple sclerosis. Mayo Clin Proc 67: 829-838
27. Lipton HL (1995) Theiler's virus infection in mice: an unusual biphasic disease process leading to demyelination. Infect Immun 11: 1147-1155
28. Lipton HL, Dal Canto MC (1979) Susceptibility of inbred mice to chronic central nervous system infection by Theiler's murine encephalomyelitis virus. Infect Immun 26: 369-374
29. Lipton HL, Dal Canto MC (1976) Theiler's virus-induced demyelination: prevention by immunosuppression. Science 192: 62-64
30. Mach F, Schonbeck U, Sukhova GK, Bourcier T, Bonnefoy JY, Pober JS, Libby P (1997) Functional CD40 ligand is expressed on human vascular endothelial cells, smooth muscle cells, and macrophages: implications for CD40-CD40 ligand signaling in atherosclerosis. Proc Nat Acad Sci USA 94: 1931-1936
31. Miller DJ, Rivera-Quinones C, Njenga MK, Leibowitz J, Rodriguez, M (1995) Spontaneous CNS remyelination in β2 microglobulin-deficient mice following virus-induced demyelination. J Neurosci 8345-8352
32. Miller DJ, Sanborn KS, Katzmann JA, Rodriguez M (1994) Monoclonal autoantibodies promote central nervous system repair in an animal model of multiple sclerosis. J Neurosci 14: 6230-6238
33. Murray PD, McGavern DB, Lin X, Njenga MK, Leibowitz J, Pease LR, Rodriguez M (1998) Perforin-dependent neurologic injury in a viral model of multiple sclerosis. J Neurosci 18: 7306-7314
34. Njenga MK, Hansen MJ, Kuhns ST, Chen LP, Rodriguez M, Pease LR (1999) Prevalent class I-restricted T-cell response to the Theiler's virus epitope Db: VP2 (121-130) in the absence of endogenous CD4 help, tumor necrosis factor alpha, gamma interferon, perforin, or costimulation through CD28. J Virol 73: 3702-3708
35. Njenga MK, Pavelko KD, Baisch J, Lin X, David C, Leibowitz J, Rodriguez M (1996) Theiler's virus persistence and demyelination in major histocompatibility complex class II-deficient mice. J Virol 70: 1729-1737
36. Oxenius A, Campbell KA, Maliszewski CR, Kishimoto T, Kikutani H, Hengartner H, Zinkernagel RM, Bachmann MF (1996) CD40-CD40L interactions are critical in T-B cooperation but not for other anti-viral CD4+ T cell functions. J Exp Med 183: 2209-2218
37. Parker DC, Greiner DL, Phillips NE, Appel MC, Steele AW, Durie FH, Noelle RJ, Mordes JP, Rossini AA (1995) Survival of mouse pancreatic islet allografts in recipients treated with allogeneic small lymphocytes and antibody to CD40 ligand. Proc Nat Acad Sci USA 92: 9560-9564
38. Patick AK, Pease LR, David CS, Rodriguez M (1990) Major histocompatibility complex-conferred resistance to Theiler's virus-induced demyelinating disease is inherited as a dominant trait in B10 congenic mice. J Virol 64: 5570-5576
39. Pierce ML, Rodriguez M (1989) Erichrome stain for myelin on osmicated tissue embedded in glycol methacrylate plastic. J Histotech 12: 35-36
40. Rivera-Quinones C, McGavern D, Schmelzer JD, Hunter SF, Low PA, and Rodriguez, M (1998) Absence of neurological deficits following extensive demyelination in a class I-deficient murine model of multiple sclerosis. Nature Medicine 4: 187-193
41. Rodriguez M, David CS (1985) Demyelination induced by Theiler's virus: influence of the H-2 haplotype. J Immunol 135: 2145-2148
42. d transgene suppresses Theiler's virus-induced demyelination in susceptible strains of mice. J Neurovirol 1: 111-117
43. b mice deficient in β 2-microglobulin. J Immunol 151: 266-276
44. Rodriguez M, Kenny JJ, Thiemann RL, Woloschak GE (1990) Theiler's virus-induced demyelination in mice immunosuppressed with anti-IgM and in mice expressing the xid gene. Microb Pathog 8: 23-35
45. Rodriguez M, Lafuse W, Leibowitz J, David CS (1986) Partial suppression of Theiler's virus-induced demyelination in vivo by administration of monoclonal antibodies to immune response gene products (Ia antigens). Neurol 36: 964-970
46. Rodriguez M, Leibowitz JL, Lampert PW (1983) Persistent infection of oligodendrocytes in Theiler's virus-induced encephalomyelitis. Ann Neurol 13: 426-433
47. Rodriguez M, Leibowitz J, David CS (1986) Susceptibility to Theiler's Virus-Induced demyelination: mapping of the gene within the H-2D region. J Exp Med 163: 620-631
48. Rodriguez M, Lennon VA (1990) Immunoglobulins promote remyelination in the central nervous system. Ann Neurol 27: 12-17
49. Rodriguez, M., Lucchinetti, C. F., Clark, R. J., Yaksh, T. L., Markowitz, H., and Lennon VA (1988) Immunoglobulins and complement in demyelination induced in mice by Theiler's virus. J Immunol 140: 800-806
50. Rodriguez M, Miller DJ, Lennon VA (1996) Immunoglobulins reactive with myelin basic protein promotes CNS remyelination. Neurol 46: 538-545
51. Rodriguez M, Nickerson C, Patick AK, David CS (1991) Expression of human HLA-B27 transgene alters susceptibility to murine Theiler's virus-induced demyelination. J Immunol 146: 2596-2602
52. Rodriguez M, Patick AK, Pease LR (1990) Abrogation of resistance to Theiler's virus-induced demyelination in C57BL mice by total body irradiation. J Neuroimmunol 26: 189-199
53. Rodriguez M, Pavelko KD, Coffman RL (1995) Gamma interferon is critical for resistance to Theiler's virus-induced demyelination. J Virol 69: 7286-7290
54. dml mice. Ann Neurol 33: 208-212
55. Rodriguez M, Sriram S (1998) Successful therapy of TMEV-induced demyelination (DA strain) with monoclonal anti lyt2.2 antibody. J Immunol 140: 2950-2955
56. Rossi CP, McAllister A, Tanguay M, Kagi D, Brahic, M (1998) Theiler's virus infection of perforin-deficient mice. J Virol 72: 4515-4519
57. Roos RP, Firestone S, Wollman R, Variakojis D, Arnason BGW (1982) The effect of short term and chronic immunosuppression on Theiler's virus demyelination. J Neuroimmunol 2: 223-234
58. Thomsen AR, Nansen A, Christensen JP, Andreasen SO, Marker O (1998) CD40 ligand is pivotal to efficient control of virus replication in mice infected with lymphocytic choriomeningitis virus. J Immunol 161: 4583-4590
59. Traugott U, Stone SH, Raine CS (1982) Chronic relapsing experimental autoimmune encephalomyelitis. Treatment with combinations of myelin components promotes clinical and structural recovery. J Neurol Sci 56: 65-73
60. Welsh CJR, Tonks P, Nash AA, Blakemore WF (1987) The effect of L3T4 T cell depletion on the pathogenesis of Theiler's murine encephalomyelitis virus infection in CBA mice. J Gen Virol 68: 1659-1667
61. Wiley JA, Harmsen AG (1995) CD40 ligand is requuired for resolution of Pneumocystis carinii pneumonia in mice. J Immunol 155: 3525-3529